The stigma around palliative care is that it is only associated with end of life, and in some minds, giving up. But that isn't the case, as palliative care is a vital part of any critical care.
Ann Culkin, MD, discusses how to ease patient fears of cancer treatment-related side effects.
Gwen Wyatt, PhD, RN, Professor, College of Nursing, Michigan State University, discusses a study that looks at acupressure to aid in relieving persistent cancer-related fatigue in breast cancer survivors.
There are multiple factors in making "cold" breast cancer tumors "hot," meaning that they respond to chemotherapy, explained Hope S. Rugo, MD, FASCO, director of Breast Oncology and Clinical Trials Education at the University of California San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center.
While the regimen was overall well tolerated, there are some adverse events for nurses to look out for.
Lung cancer remains the leading cause of cancer mortality, killing more Americans than breast, colon, and prostate cancer combined—and Kentucky is the epicenter of lung cancer in the United States.
Significant advances have been made in diagnosing and treating bladder cancer, allowing for improved patient outcomes.
Susan Moore on the Importance of Oral Oncolytic Patient Education
Radiation therapy is key in treating patients with small cell and non-small cell lung cancer, explained Terence T. Sio, MD, MS, radiation oncologist and assistant professor of radiation oncology at the Mayo Clinic.
Oncology nurses are key players in helping patients with cancer find clinical trials, explained Martha Raymond, founder and CEO of the Raymond Foundation.
Being recognized as a lung cancer advocate made me realize how important even the smallest role in this fight can be.
Palliative care can be beneficial to patients treated with hematopoietic stem cell transplantation.
Supplements are well-tolerated (and can be beneficial) to patients with advanced pancreatic cancer, according to a small study.
Kim Noonan, MS, RN, ANP, AOCN, chief nurse practitioner, Center for Neuro-Oncology, Dana-Farber Cancer Institute, discusses the challenges of treating patients with multiple myeloma.
Linda Casey, BSN, OCN, a nurse at the John Theurer Cancer Center, discusses working with and treating patients who are diagnosed with blood cancer.
Beth Sandy discusses the use of anti-psychotoci agent, olanzapine, when managing chemotherapy-induced nausea and vomiting (CINV).
Nadine Barrett, Ph.D., director of the Office of Health Equity and Disparities at the Duke Cancer Institute, discusses the importance of creating meaningful community partnerships that can improve health outcomes.
Both par­ents and clinicians need more valid information to guide them on how to interact with a child during painful procedures related to cancer treatment.
The indication for the DigniCap Cooling System has been expanded by the FDA to include alopecia reduction across all solid tumors.
Ashley Dietrich was diagnosed with Hodgkin's Lymphoma while pregnant at 6 weeks. Ashley's son, Beckett Anthony, was born in 2011.
One expert discusses findings from the TAILORx study.
A guide for oncology nurses on navigating the ever-growing field of direct-to-consumer genetic testing.
Research on the role of spirituality in healthcare continues to grow, and for patients with cancer, religious and spiritual values can be especially important to their overall quality of life throughout their cancer journey.
If a nurse inadvertently connects an enteral device to another type of tube such as intravenous line or tracheal tube, it can cause the patient harm. Specialized connectors can prevent this from happening.
Lauren Berger, MPH, Senior Director of Patient Services Programs at the Leukemia and Lymphoma Society discusses some of the programs offered by the foundation specifically for oncology nurses.
Using mobile apps and other new technologies, clinicians can better monitor and help their patients.
Makers of breast implants should supplement their labeling to include a boxed warning about health problems that can arise from the devices, along with a patient decision checklist that highlights those concerns, according to final guidance issued today by the Food and Drug Administration.
Brian Untch, MD, assistant member, Department of Surgery, Gastric and Mixed Tumor Service, Head and Neck Service, Memorial Sloan Kettering Cancer Center, discusses the watchful waiting approach for patients with neuroendocrine tumors (NETs).